Cargando…

Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews

BACKGROUND: Critics of systematic reviews have argued that these studies often fail to inform clinical decision making because their results are far too general, that the data are sparse, such that findings cannot be applied to individual patients or for other decision making. While there is some co...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagnier, Joel J, Morgenstern, Hal, Altman, Doug G, Berlin, Jesse, Chang, Stephanie, McCulloch, Peter, Sun, Xin, Moher, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847163/
https://www.ncbi.nlm.nih.gov/pubmed/24004523
http://dx.doi.org/10.1186/1471-2288-13-106
_version_ 1782293554101485568
author Gagnier, Joel J
Morgenstern, Hal
Altman, Doug G
Berlin, Jesse
Chang, Stephanie
McCulloch, Peter
Sun, Xin
Moher, David
author_facet Gagnier, Joel J
Morgenstern, Hal
Altman, Doug G
Berlin, Jesse
Chang, Stephanie
McCulloch, Peter
Sun, Xin
Moher, David
author_sort Gagnier, Joel J
collection PubMed
description BACKGROUND: Critics of systematic reviews have argued that these studies often fail to inform clinical decision making because their results are far too general, that the data are sparse, such that findings cannot be applied to individual patients or for other decision making. While there is some consensus on methods for investigating statistical and methodological heterogeneity, little attention has been paid to clinical aspects of heterogeneity. Clinical heterogeneity, true effect heterogeneity, can be defined as variability among studies in the participants, the types or timing of outcome measurements, and the intervention characteristics. The objective of this project was to develop recommendations for investigating clinical heterogeneity in systematic reviews. METHODS: We used a modified Delphi technique with three phases: (1) pre-meeting item generation; (2) face-to-face consensus meeting in the form of a modified Delphi process; and (3) post-meeting feedback. We identified and invited potential participants with expertise in systematic review methodology, systematic review reporting, or statistical aspects of meta-analyses, or those who published papers on clinical heterogeneity. RESULTS: Between April and June of 2011, we conducted phone calls with participants. In June 2011 we held the face-to-face focus group meeting in Ann Arbor, Michigan. First, we agreed upon a definition of clinical heterogeneity: Variations in the treatment effect that are due to differences in clinically related characteristics. Next, we discussed and generated recommendations in the following 12 categories related to investigating clinical heterogeneity: the systematic review team, planning investigations, rationale for choice of variables, types of clinical variables, the role of statistical heterogeneity, the use of plotting and visual aids, dealing with outlier studies, the number of investigations or variables, the role of the best evidence synthesis, types of statistical methods, the interpretation of findings, and reporting. CONCLUSIONS: Clinical heterogeneity is common in systematic reviews. Our recommendations can help guide systematic reviewers in conducting valid and reliable investigations of clinical heterogeneity. Findings of these investigations may allow for increased applicability of findings of systematic reviews to the management of individual patients.
format Online
Article
Text
id pubmed-3847163
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38471632013-12-04 Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews Gagnier, Joel J Morgenstern, Hal Altman, Doug G Berlin, Jesse Chang, Stephanie McCulloch, Peter Sun, Xin Moher, David BMC Med Res Methodol Research Article BACKGROUND: Critics of systematic reviews have argued that these studies often fail to inform clinical decision making because their results are far too general, that the data are sparse, such that findings cannot be applied to individual patients or for other decision making. While there is some consensus on methods for investigating statistical and methodological heterogeneity, little attention has been paid to clinical aspects of heterogeneity. Clinical heterogeneity, true effect heterogeneity, can be defined as variability among studies in the participants, the types or timing of outcome measurements, and the intervention characteristics. The objective of this project was to develop recommendations for investigating clinical heterogeneity in systematic reviews. METHODS: We used a modified Delphi technique with three phases: (1) pre-meeting item generation; (2) face-to-face consensus meeting in the form of a modified Delphi process; and (3) post-meeting feedback. We identified and invited potential participants with expertise in systematic review methodology, systematic review reporting, or statistical aspects of meta-analyses, or those who published papers on clinical heterogeneity. RESULTS: Between April and June of 2011, we conducted phone calls with participants. In June 2011 we held the face-to-face focus group meeting in Ann Arbor, Michigan. First, we agreed upon a definition of clinical heterogeneity: Variations in the treatment effect that are due to differences in clinically related characteristics. Next, we discussed and generated recommendations in the following 12 categories related to investigating clinical heterogeneity: the systematic review team, planning investigations, rationale for choice of variables, types of clinical variables, the role of statistical heterogeneity, the use of plotting and visual aids, dealing with outlier studies, the number of investigations or variables, the role of the best evidence synthesis, types of statistical methods, the interpretation of findings, and reporting. CONCLUSIONS: Clinical heterogeneity is common in systematic reviews. Our recommendations can help guide systematic reviewers in conducting valid and reliable investigations of clinical heterogeneity. Findings of these investigations may allow for increased applicability of findings of systematic reviews to the management of individual patients. BioMed Central 2013-08-30 /pmc/articles/PMC3847163/ /pubmed/24004523 http://dx.doi.org/10.1186/1471-2288-13-106 Text en Copyright © 2013 Gagnier et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gagnier, Joel J
Morgenstern, Hal
Altman, Doug G
Berlin, Jesse
Chang, Stephanie
McCulloch, Peter
Sun, Xin
Moher, David
Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews
title Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews
title_full Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews
title_fullStr Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews
title_full_unstemmed Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews
title_short Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews
title_sort consensus-based recommendations for investigating clinical heterogeneity in systematic reviews
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847163/
https://www.ncbi.nlm.nih.gov/pubmed/24004523
http://dx.doi.org/10.1186/1471-2288-13-106
work_keys_str_mv AT gagnierjoelj consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews
AT morgensternhal consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews
AT altmandougg consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews
AT berlinjesse consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews
AT changstephanie consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews
AT mccullochpeter consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews
AT sunxin consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews
AT moherdavid consensusbasedrecommendationsforinvestigatingclinicalheterogeneityinsystematicreviews